News | June 08, 2015

Steinberg Diagnostic Medical Imaging Installs First Toshiba Celesteion PET/CT in the U.S.

Wide-bore system emphasizes comfort for all patient types with high-quality images

Toshiba, Celesteion, Steinberg Diagnostic Medical Imaging, U.S., first

June 8, 2015 - Steinberg Diagnostic Medical Imaging (SDMI) of Las Vegas has bolstered its capabilities by installing the United States' first Celesteion PET/CT system from Toshiba America Medical Systems Inc. The Celesteion allows SDMI to provide the highest quality PET/CT (positron emission tomography/computed tomography) images and exams without sacrificing patient comfort.

"With the Celesteion, we found a wide-bore system that let us scan a variety of patients comfortably, as well as being a more-than-capable planning device for both PET and CT radiation therapy," said Mark Winkler, M.D., professor of health sciences at the University of Nevada, Las Vegas and founding partner of SDMI. "It's become the preferred system among our patients, as well as giving us the long term outlook of more referrals with the increase in oncological offerings."

The Celesteion is designed with the patient in mind, with features that include:

  • 90 cm CT bore and 88 cm PET bore – Offering a feeling of openness and versatile patient positioning;
  • Fast and accurate diagnoses – Accurate lesion detection with time of flight technology and a 70 cm PET and CT field-of-view;
  • System versatility – The Celesteion can perform diagnostic CT imaging, CT interventions, PET/CT imaging and CT radiation oncology simulation scans; and
  • CT dose reduction – Ensuring patient safety is not a choice, Celesteion comes standard with Toshiba's most advanced CT dose reduction technology, AIDR 3D, and conforms to the requirements of MITA's XR-29 Smart Dose Standard

 

For more information: www.medical.toshiba.com

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...